COMMUNIQUÉS West-GlobeNewswire

NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Clearance to Proceed with Clinical Trial of NRX-101 in Combination with Robotic-enabled Transcranial Magnetic Stimulation in Patients with Depression and Suicidality
07/05/2026
Preliminary research suggests that D-cycloserine significantly enhances the effect of Transcranial Magnetic Stimulation (TMS) Trial is planned to be conducted at a leading US academic teaching hospital, three HOPE [...]
Prime Medicine Reports First Quarter 2026 Financial Results and Provides Business Updates
07/05/2026
-- On track to file IND and/or CTA for PM577 in Wilson Disease in H1 2026 and for PM647 in AATD mid-2026; initial clinical data from both programs expected in 2027 -- -- Continued regulatory dialogue with the FDA toward [...]
Celcuity Schedules Release of First Quarter 2026 Financial Results and Webcast/Conference Call
07/05/2026
MINNEAPOLIS, May 07, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its [...]
Tria Federal Unveils Integrated Solutions Platform and New Website
07/05/2026
Tria helps federal health agencies achieve their critical missions by navigating complex tradeoffs between cost, quality, and access to care ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Tria Federal has unveiled a [...]
SS Innovations Demonstrates Long-Distance Telesurgery Capabilities at Royal Australian College of Surgeons Annual Scientific Congress
07/05/2026
Landmark telesurgery performed in Perth, Australia, more than 4,500 miles from the patient in India, utilizing the SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console FORT LAUDERDALE, Fla., May 07 [...]
Xenon MRI Advances as a Cardiopulmonary Biomarker Platform at ATS 2026
07/05/2026
20+ presentations highlight expanding role in pediatric lung disease, treatment-response assessment, and pharma trial endpoints DURHAM, NC and LONDON, May 07, 2026 (GLOBE NEWSWIRE) -- Polarean, a commercial-stage [...]
vTv Therapeutics to Participate in Upcoming May Investor Conferences
07/05/2026
HIGH POINT, N.C., May 07, 2026 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin , a novel, potential first-in-class oral [...]
Solid Biosciences Doses First Participant in Phase 3 IMPACT DUCHENNE Clinical Trial Evaluating SGT-003 in Duchenne Muscular Dystrophy
07/05/2026
- Initiation of Phase 3 IMPACT DUCHENNE placebo-controlled, randomized, double-blind trial as part of Solid’s integrated, multi-trial development program designed to support registration and global regulatory [...]
Biotech’s Next Wave May Already be in Motion
07/05/2026
Insider Bets on what may become a Brain Cancer Moonshot DENVER, May 07, 2026 (GLOBE NEWSWIRE) -- ( www.247marketnews.com and NeOnc Technology) - The biotech and pharma sector is entering one of its most pivotal periods [...]
Most Vision Loss Is Preventable—20+ Eye Care, Neurology and Integrative Medicine Experts Unite for Free Global Summit This May
07/05/2026
Five-day virtual event during Healthy Vision Month in May will deliver science-based strategies for preventing vision loss and optimizing eye and brain health for patients and healthcare professionals With vision loss [...]
Virbac : Declaration of the number of shares and voting rights 04/2026
07/05/2026
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]
Scarlet Therapeutics Demonstrates In Vivo Survival of Lab-Grown Universal Red Blood Cells Equivalent to Donated Blood
07/05/2026
£3.2M Seed Round Closed to Accelerate Platform Development BRISTOL, United Kingdom, May 07, 2026 (GLOBE NEWSWIRE) -- Scarlet Therapeutics ("Scarlet") today announces a landmark preclinical result: its proprietary cell- [...]
Moongrade Releases Astrology App Designed to Deliver Personalized Birth Charts and Unlimited Compatibility Insights
07/05/2026
Moongrade offers personalized birth charts and unlimited love compatibility insights for deeper self-discovery NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- Moongrade has launched a personalized astrology app designed to [...]
Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
07/05/2026
The Boards of Directors of Angelini Pharma and Catalyst Pharmaceuticals have unanimously approved the acquisition of Catalyst Pharmaceuticals at 31.50 USD per share in cash, for a total consideration of approximately 4. [...]
Virbac : Déclaration d'actions et de droits de vote 04/2026
07/05/2026
DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions composant le capital (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) [...]
Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis Registrational Trial
07/05/2026
ZUG, Switzerland, May 07, 2026 (GLOBE NEWSWIRE) -- Special Protocol Assessment (SPA) agreement with the U.S. FDA provides regulatory alignment on the registrational path for Privosegtor in optic neuritis (ON) FDA [...]
ViaNautis Bio to present its targeted polyNaut® nanovesicles (tPNVs) for the generation of in vivo CAR-T therapies at ASGCT Annual Meeting
07/05/2026
Targeted polyNaut® nanovesicles (tPNVs) are ViaNautis’ proprietary, polymer-based delivery platform for oligonucleotides enabling cell ‑ specific targeting through nanobody conjugation CD8 nanobody conjugated tPNVs are [...]
TOMI Environmental Solutions (Nasdaq: TOMZ) Clarifies Previously Announced $120M Preferred Stock LOI to Merge with Carbonium Core, Entering U.S. Nuclear-Grade Graphite Market for Advanced Reactors Within a $13–15B Global Graphite Industry
07/05/2026
Establishes domestic platform in advanced graphite, addressing a multi-billion-dollar end market underpinned by U.S. supply-chain reshoring and next-generation nuclear deployment TOMI Environmental Solutions, Inc. and [...]
Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis Registrational Trial
07/05/2026
Special Protocol Assessment (SPA) agreement with the U.S. FDA provides regulatory alignment on the registrational path for Privosegtor in optic neuritis (ON) FDA Breakthrough Therapy and EMA PRIME designations in ON [...]

Pages